Free Trial
→ You’re Being LIED To About The Iran War (From Banyan Hill Publishing) (Ad)tc pixel Free CBIO Stock Alerts

Crescent Biopharma (CBIO) Institutional Ownership

Crescent Biopharma logo
$18.06 -0.02 (-0.11%)
Closing price 05/6/2026 04:00 PM Eastern
Extended Trading
$18.07 +0.01 (+0.03%)
As of 05/6/2026 06:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Institutional Ownership Changes (13F Filings) for Crescent Biopharma (NASDAQ:CBIO)

Current
Institutional Ownership
Percentage
75.19%
Number of
Institutional Buyers
(last 12 months)
35
Total
Institutional Inflows
(last 12 months)
$178.25M
Number of
Institutional Sellers
(last 12 months)
6
Total
Institutional Outflows
(last 12 months)
$1.49M
Get CBIO Insider Trade Alerts

Want to know when executives and insiders are buying or selling Crescent Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Chart & View Institutional Buying and Selling Data

CBIO Institutional Buying and Selling by Quarter

Crescent Biopharma Major Shareholders & Ownership History

Export
Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/6/2026Jennison Associates LLC152,974$2.81M0.0%N/A0.555%
4/21/2026 Cannon Global Investment Management LLC10,200$187K0.4%N/A0.073%
2/18/2026ADAR1 Capital Management LLC606,000$7.19M0.5%N/A4.362%
2/18/2026Vestal Point Capital LP1,500,000$17.79M0.6%N/A10.797%
2/18/2026Tang Capital Management LLC872,398$10.35M0.5%+28.3%6.279%
2/18/2026Quadrature Capital Ltd13,246$157K0.0%N/A0.095%
2/18/2026RTW Investments LP372,856$4.42M0.0%N/A2.684%
2/18/2026Opaleye Management Inc.1,178,300$13.98M1.8%N/A8.483%
2/18/2026Millennium Management LLC61,882$734K0.0%N/A0.446%
2/18/2026Moore Capital Management LP25,000$296K0.0%N/A0.180%
2/18/2026Balyasny Asset Management L.P.111,715$1.33M0.0%N/A0.804%
2/18/2026BVF Inc. IL2,748,763$32.60M1.1%+98.1%19.790%
2/17/2026ADAR1 Capital Management LLC606,000$7.19M0.5%N/A4.363%
2/17/2026Burkehill Global Management LP74,000$844K0.1%N/A0.533%
2/17/2026Heights Capital Management Inc.264,000$3.13M1.1%N/A1.901%
2/17/2026Price T Rowe Associates Inc. MD338,125$4.01M0.0%-11.9%2.434%
2/17/2026Fcpm Iii Services B.V.1,677,852$19.90M2.6%N/A12.080%
2/16/2026OMERS ADMINISTRATION Corp11,600$138K0.0%N/A0.084%
2/16/2026NEXTBio Capital Management LP372,856$4.42M2.6%N/A2.684%
2/13/2026Marshall Wace LLP21,826$259K0.0%-50.0%0.157%
2/13/2026Alyeska Investment Group L.P.264,000$3.11M0.0%N/A1.901%
2/13/2026State Street Corp26,217$311K0.0%+40.8%0.189%
2/12/2026Jane Street Group LLC22,965$272K0.0%N/A0.165%
2/12/2026HRT Financial LP13,083$155K0.0%N/A0.094%
2/12/2026Renaissance Technologies LLC46,700$554K0.0%+73.6%0.336%
2/10/2026Goldman Sachs Group Inc.25,245$299K0.0%-31.7%0.182%
2/9/2026Geode Capital Management LLC91,079$1.08M0.0%+31.7%0.656%
2/9/2026Jefferies Financial Group Inc.64,244$762K0.0%-37.5%0.462%
11/17/2025Citadel Advisors LLC25,593$304K0.0%N/A0.184%
11/17/2025Commodore Capital LP450,829$5.36M0.3%-0.6%3.245%
11/17/2025Bank of America Corp DE3,863$46K0.0%-58.2%0.028%
11/14/2025Two Sigma Investments LP28,318$337K0.0%N/A0.204%
11/13/2025Jefferies Financial Group Inc.102,714$1.22M0.0%+279.1%0.739%
11/7/2025Vanguard Group Inc.657,900$7.82M0.0%N/A3.365%
8/15/2025Soleus Capital Management L.P.400,000$6.46M0.4%N/A2.046%
8/15/2025Perceptive Advisors LLC453,686$7.32M0.7%N/A2.321%
8/15/2025Frazier Life Sciences Management L.P.453,685$7.32M0.3%N/A2.321%
8/15/2025Braidwell LP261,504$4.22M0.1%N/A1.338%
8/15/2025BVF Inc. IL1,387,863$22.40M0.8%N/A7.099%
8/15/2025Bank of America Corp DE9,231$149K0.0%N/A0.047%
8/15/2025Adage Capital Partners GP L.L.C.100,912$1.63M0.0%N/A0.516%
8/14/2025Commodore Capital LP453,686$7.32M0.5%N/A2.321%
8/13/2025Affinity Asset Advisors LLC280,031$4.52M0.6%N/A1.432%
8/12/2025Jefferies Financial Group Inc.27,096$437K0.0%N/A0.139%
8/7/2023Acadian Asset Management LLC144,028$50K0.0%-44.5%0.381%
2/15/2023Nantahala Capital Management LLC438,055$231K0.0%-82.9%1.392%
11/10/2022Nantahala Capital Management LLC2,554,735$1.29M0.1%-7.3%8.116%
11/7/2022Virtu Financial LLC189,175$95K0.0%+250.5%0.601%
8/15/2022Nantahala Capital Management LLC2,755,903$4.91M0.2%+13.8%8.755%
8/13/2022Virtu Financial LLC53,977$96K0.0%N/A0.171%
2/10/2022Acadian Asset Management LLC232,400$211K0.0%N/A0.740%
2/8/2022Raymond James & Associates32,800$30K0.0%-74.7%0.104%


CBIO Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of CBIO shares?

During the previous two years, 38 institutional investors and hedge funds held shares of Crescent Biopharma. The most heavily invested institutionals were BVF Inc. IL ($32.60M), Fcpm Iii Services B.V. ($19.90M), Vestal Point Capital LP ($17.79M), Opaleye Management Inc. ($13.98M), Tang Capital Management LLC ($10.35M), Vanguard Group Inc. ($7.82M), and Perceptive Advisors LLC ($7.32M).Learn more on Crescent Biopharma's institutional investors.

What percentage of Crescent Biopharma's stock is owned by institutional investors?

75.19% of Crescent Biopharma's stock is owned by institutional investors. Learn more on CBIO's institutional investor holdings.

Which institutional investors have been buying Crescent Biopharma's stock?

Of the 35 institutional investors that purchased Crescent Biopharma's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BVF Inc. IL ($2.75M), Fcpm Iii Services B.V. ($1.68M), Vestal Point Capital LP ($1.50M), ADAR1 Capital Management LLC ($1.21M), Opaleye Management Inc. ($1.18M), Vanguard Group Inc. ($657.90K), and Perceptive Advisors LLC ($453.69K).

How much institutional buying is happening at Crescent Biopharma?

Institutional investors have bought a total of 13,556,471 shares in the last 24 months. This purchase volume represents approximately $178.25M in transactions.

Which of Crescent Biopharma's major shareholders have been selling company stock?

The following institutional investors have sold Crescent Biopharma stock in the last 24 months: Price T Rowe Associates Inc. MD ($45.47K), Jefferies Financial Group Inc. ($38.47K), Marshall Wace LLP ($21.87K), Goldman Sachs Group Inc. ($11.73K), Bank of America Corp DE ($5.37K), and Commodore Capital LP ($2.86K).

How much institutional selling is happening at Crescent Biopharma?

Institutional investors have sold a total of 125,763 shares in the last 24 months. This volume of shares sold represents approximately $1.49M in transactions.


Related Companies

This page (NASDAQ:CBIO) was last updated on 5/7/2026 by MarketBeat.com Staff.
From Our Partners
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Sell 99% of Your Stocks, Do THIS Instead…
Millionaire Trader Exposes: "The Single Stock Income Plan" With over 6,000 stocks on the market to choose ...
The Oxford Club | Sponsoredtc pixel
Trade this between 9:30 and 10:45 am EST
The first 75 minutes of the trading day may be the most overlooked window for consistent opportunities.If you ...
Base Camp Trading | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Elon Unveils AI Passive Income Stream for Millions of Americans
During Tesla's last earnings call, Elon Musk outlined a new AI-driven approach he says could generate $30,000-...
InvestorPlace | Sponsoredtc pixel
Invest in SpaceX Before IPO
SpaceX is already one of the most valuable private companies on Earth, and some analysts believe its valuation...
NXT Wave Research | Sponsoredtc pixel
Satellite Images Spot Potential $10 Trillion Discovery
'Dark Energy': Elon Musk's Next Potential $10 Trillion Move A highly secure site in West Texas now houses a...
Altimetry | Sponsoredtc pixel